Literature DB >> 16565157

Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.

Philippe R S Lagacé-Wiens, Kim A Nichol, Lindsay E Nicolle, Mel DeCorby, Melissa McCracken, Michael R Mulvey, George G Zhanel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16565157     DOI： 10.1093/jac/dkl102

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  First description of an extended-spectrum-beta-lactamase-producing multidrug-resistant Escherichia fergusonii strain in a patient with cystitis.

Authors:  Philippe R S Lagacé-Wiens; Patricia J Baudry; Paulette Pang; Gregory Hammond
Journal:  J Clin Microbiol       Date:  2010-04-21       Impact factor: 5.948

2.  In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli.

Authors:  M Tärnberg; A Ostholm-Balkhed; H-J Monstein; A Hällgren; H Hanberger; L E Nilsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-06       Impact factor: 3.267

3.  Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series.

Authors:  James Cohen Stuart; Maurine Leverstein-Van Hall; Willemijn Kortmann; J Verlind; Frouke Mulder; Jelle Scharringa; Ad Fluit; Miquel Ekkelenkamp
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-16       Impact factor: 3.267

Review 4.  Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices.

Authors:  Johann D D Pitout
Journal:  Drugs       Date:  2010-02-12       Impact factor: 9.546

5.  Effects of Antibiotic Cycling Policy on Incidence of Healthcare-Associated MRSA and Clostridioides difficile Infection in Secondary Healthcare Settings.

Authors:  Geraldine Mary Conlon-Bingham; Mamoon Aldeyab; Michael Scott; Mary Patricia Kearney; David Farren; Fiona Gilmore; James McElnay
Journal:  Emerg Infect Dis       Date:  2019-01       Impact factor: 6.883

6.  Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study.

Authors:  Galo Peralta; María Lamelo; Patricia Alvarez-García; María Velasco; Alberto Delgado; Juan Pablo Horcajada; María Montero; María Pía Roiz; Maria Carmen Fariñas; Juan Alonso; Luis Martínez Martínez; Alfonso Gutiérrez-Macías; Jose Angel Alava; Azucena Rodríguez; Ana Fleites; Vicente Navarro; Elia Sirvent; Jose Antonio Capdevila
Journal:  BMC Infect Dis       Date:  2012-10-05       Impact factor: 3.090

7.  Optimization and evaluation of Flexicult® Vet for detection, identification and antimicrobial susceptibility testing of bacterial uropathogens in small animal veterinary practice.

Authors:  Luca Guardabassi; Sandra Hedberg; Lisbeth Rem Jessen; Peter Damborg
Journal:  Acta Vet Scand       Date:  2015-10-26       Impact factor: 1.695
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.